Navigation Links
Alnylam Reports Results of Human Experimental Infection Model with,Respiratory Syncytial Virus

udy to assess the safety and tolerability of intranasally delivered ALN-RSV01 versus placebo, administered to healthy adult volunteers experimentally inoculated with the RSV virus. The study, expected to enroll approximately 90 subjects, aims to determine the safety and anti-viral activity of ALN-RSV01 as measured toward clinical symptoms of RSV infection and RSV infection rate based on measures of viral load.

About Respiratory Syncytial Virus (RSV)

RSV is a highly contagious virus that causes infections in both the upper and lower respiratory tract. RSV infects nearly every child at least once by the age of two years and is a leading cause of hospitalization due to respiratory infection in children and in people with compromised immune systems, and others. RSV infection typically results in cold-like symptoms but can lead to more serious respiratory illnesses such as croup, pneumonia, bronchiolitis, and in extreme cases, death. RSV infection in the pediatric population accounts for more than 125,000 hospitalizations per year in the U.S. In addition, RSV infection in infants has been linked to the development of childhood asthma. As a result, there is a significant need for novel therapeutics to treat patients who become infected with RSV.

About RNA Interference (RNAi)

RNA interference (or RNAi) is a naturally occurring mechanism within cells for selectively silencing and regulating specific genes. The discovery of RNAi has been widely acknowledged as a major breakthrough in biology, and the technology was recognized for its potential broad impact in medicine with the award of the 2006 Nobel Prize for Physiology or Medicine. Since many diseases are caused by the inappropriate activity of specific genes, the ability to silence genes selectively through RNAi has accelerated the understanding of these genes and their related pathways. Additionally, RNAi could provide a new way to treat a wide range of human diseases. RNAi is induced by small
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
2. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:4/17/2015)... DALLAS , Apr. 17, 2015 Steven ... ( ALGA ), and its operating subsidiary American Seed ... an exclusive presentation to investors yesterday in New York ... Strategy. The American Seed & Oil Company ... , Hippie Butter Hemp Seed Foods , the ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research ... announced the addition of the "The Corporate ... 2014 - Global Edition " report to ... Pharmafrom a Patient Perspective, is now in its ... (2014 results; published early 2015). For each annual ...
Breaking Medicine Technology:American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... , BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, ... human clinical trial of its norovirus vaccine. The Phase ... investigational, nasally-delivered, dry powder vaccine in healthy adults. The study ... infection by including a live virus challenge of subjects that ...
... , SEATTLE, Sept. 5 ... that the U.S. Food and Drug Administration (FDA) has notified ... date of April 23, 2010 under standard review has been ... relapsed or refractory aggressive non-Hodgkin,s lymphoma (NHL). Pixantrone has fast ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA 2FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA 3
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Riviera ... Dr. Kevin Sadati of the Gallery of Cosmetic ... County’s top beauty experts. The publication focused on ... facial stem cell fat grafting, eyelid surgery, laser resurfacing ... facial plastic surgery has resulted in thousands of ...
(Date:4/17/2015)... Tampa, Florida (PRWEB) April 17, 2015 ... Term Acute Care and Florida Hospital Carrollwood were all ... Hospital Wesley Chapel, located in Pasco County, is ranked ... Bay Times workplaces survey, which was conducted in partnership ... is an 83 all-private bed hospital that opened in ...
(Date:4/17/2015)... April 17, 2015 From the day Dr. ... the Texas non-profit organization has empowered young people to create ... to bring fresh water and the Gospel to all ... University. Between March 17 and 27, students, faculty and staff ... Liberians with fresh water and the Good News of Jesus. ...
(Date:4/17/2015)... CA (PRWEB) April 17, 2015 Consumers ... insurance protection without modifications can now use the Insurance ... general life insurance policy rates that are featured by ... The standard plans that are offered are mixed between ... aged 18 to 79. There are now term, universal ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2
... in mice led to premature ovarian failure, researchers report ... they have discovered a mechanism that prompts early menopause ... , PTEN -- a gene that,s known for suppressing ... the ovary from ripening too quickly. When researchers deleted ...
... The new product development,process is exceedingly complex. It ... hundreds of millions of dollars in capital resources.,Not ... so complex that no single person in the ... For this reason, benchmark partners emphasize the importance ...
... leaders will,convene in Arlington, Virginia, March 6-8, 2008 ... strategies for the treatment of,common malignancies. State-of-the-art technology ... The Summit will provide 13.75 CME credits ... Foundation, and the content is being,developed under the ...
... Feb. 1, two,giant heart-shaped light displays will light up ... and remind women to take,care of their hearts all ... displays will adorn both,the north and south sides of ... downtown Detroit. The large red hearts show support,for American ...
... an infection caused by Onchocerca volvulus, a parasite nematode ... fly of the Simulium genus whose larvae develop in ... skin lesions but also eye damage that can lead ... blindness. A huge majorityy -- 99% -- of the ...
... hospitals already stocked with simple, inexpensive solution , , THURSDAY, Jan. ... sulfate) given just before delivery to pregnant women at high ... among these newborns in half, U.S. researchers report. , The ... States. All the women were at high risk for giving ...
Cached Medicine News:Health News:Study Spots Gene That Plays Role in Infertility 2Health News:Pharma Product Commercialization: Standardized Team Processes Help Save Complex Drug Launches 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:Heart-Shaped Light Displays on Blue Cross Blue Shield of Michigan Building Show Support for American Heart Month, National Wear Red Day 2Health News:The onchocerciasis parasite showing signs of resistance 2Health News:The onchocerciasis parasite showing signs of resistance 3Health News:Epsom Salt Cut Cerebral Palsy Rate in Half Among Preemies 2
... tradition of the USA Series, ACMITM introduces ... Elite System II -- the longest cystourethroscope ... Elite System offers the components you need ... USA Elite System II Cystourethroscopes provide all ...
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Inquire...
... Surgical MicroChoice® system is a set ... be operated using the Advantage®, PowerPro®, ... designed for use in the drilling, ... in a wide variety of procedures ...
Medicine Products: